Gareth Gerrard
Papers
1
Total Citations
15
H-Index
1
About
Gareth Gerrard is a clinical scientist whose work centers on the molecular monitoring of hematological malignancies, with a particular focus on improving the accuracy and efficiency of *BCR-ABL1* detection. His major contribution lies in advancing reverse transcription quantitative polymerase chain reaction (RT-qPCR) technologies, a cornerstone for managing patients with chronic myeloid leukemia. Gerrard’s research has driven innovation in "fast-mode duplex qPCR," a method designed to automate and harmonize the molecular monitoring process, thereby enhancing the sensitivity and reproducibility of disease-level tracking. This work, detailed in his highly cited 2012 paper, addresses the critical need for standardized protocols in clinical labs, directly impacting patient care by enabling more reliable treatment response assessments. With over 15 citations, his findings have helped shape best practices for *BCR-ABL1* monitoring, reducing variability between testing centers. Gerrard’s achievements underscore a commitment to bridging laboratory innovation with clinical application, making his research essential for students and professionals aiming to understand the evolution of molecular diagnostics in oncology.
Research Focus
Key Achievements
Top Papers
- 1